About Engevity News

Studies rarely say what the headline about them says. Engevity News reads the papers themselves, noting sample size, design, effect size and funding, then reports what a result supports and what it does not. Coverage spans health research, laboratory science and the innovation pipeline, for readers who want a finding placed against the evidence that already exists. A single paper is a data point rather than a conclusion.

The format is analysis and explanation. A brief states the study design first, the result second, and the limitations third; observational data is never described as proof of cause. Preprints are labeled as preprints. Single-study reversals of long-standing evidence are treated skeptically, and university press releases are compared with the paper before anything is written. Effect sizes are given in absolute terms wherever the underlying data allows it. Citations point to the original study, never to a summary of a summary.

Science covers findings across biology, physics, climate and medicine with the methods included. Research follows how work gets funded, reviewed, replicated and occasionally retracted. Innovation tracks laboratory results moving toward products, with realistic timelines. Literacy teaches the reading skills, from confidence intervals to conflict-of-interest statements, that make the rest usable. Briefings condenses a week of papers into short dated summaries. Science News reports announcements as they are made, and Business News covers the companies, funders and journals with money in the outcome.

Engevity News appears under VUGA Media Group, one of the titles operating in the VUGA Enterprises Network.